MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-30-2025
Abbott Laboratories Operating Cash Flow 2011-2025 | ABT
Annual Operating Cash Flow Abbott Laboratories
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.56 B | 7.26 B | 9.58 B | 10.5 B | 7.9 B | 6.14 B | 6.3 B | 5.57 B | 3.2 B | 2.97 B | 3.68 B | 3.32 B | 9.31 B | 8.97 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.5 B | 2.97 B | 6.66 B |
Quarterly Operating Cash Flow Abbott Laboratories
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 1.42 B | - | - | 1.02 B | - | - | 1.14 B | - | 7.26 B | - | 2.06 B | - | 7.47 B | - | 2.64 B | - | 4.1 B | 2.04 B | 715 M | - | 3.72 B | 1.77 B | 712 M | - | 4.54 B | 2.35 B | 1.11 B | - | 3.93 B | 1.92 B | 574 M | - | 2.03 B | 816 M | -93 M | - | 2.14 B | 943 M | 2 M | - | 2.44 B | 1.24 B | 336 M | - | 1.7 B | 1.18 B | 460 M | - | 7.81 B | 4.29 B | 2.22 B | - | - | - | 2.01 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.81 B | -93 M | 2.29 B |
Operating Cash Flow of other stocks in the Medical devices industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
275 M | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
-63.1 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-4.1 M | - | 3.58 % | $ 2.21 M | USA |
 |
Apyx Medical Corporation
APYX
|
-5.25 M | $ 3.47 | -3.61 % | $ 120 M | USA |
 |
Boston Scientific Corporation
BSX
|
3.44 B | $ 96.06 | -0.04 % | $ 141 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
46.8 M | $ 9.35 | -1.99 % | $ 671 M |  Israel |
 |
Bio-Rad Laboratories
BIO
|
455 M | $ 303.76 | 0.52 % | $ 8.57 B | USA |
 |
Apollo Endosurgery
APEN
|
-31.3 M | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
-50.2 M | - | - | $ 16.4 M | USA |
 |
Eargo
EAR
|
-117 M | - | - | $ 10.2 M | USA |
 |
BioSig Technologies
BSGM
|
-4.76 M | - | 37.08 % | $ 85.7 M | USA |
 |
Cardiovascular Systems
CSII
|
-24.3 M | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
251 M | $ 47.89 | -0.48 % | $ 7.14 K | USA |
 |
Cutera
CUTR
|
-138 M | - | -10.19 % | $ 1.99 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-13.6 M | $ 3.3 | 11.09 % | $ 123 M |  France |
 |
Neovasc
NVCN
|
-27.1 M | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
133 M | $ 14.62 | 1.04 % | $ 1.16 B | Israel |
 |
Dynatronics Corporation
DYNT
|
301 K | - | 14.99 % | $ 929 K | USA |
 |
IRIDEX Corporation
IRIX
|
-6.74 M | $ 1.21 | 6.14 % | $ 19.5 M | USA |
 |
Second Sight Medical Products
EYES
|
-20.8 M | - | -0.97 % | $ 54.4 M | USA |
 |
LivaNova PLC
LIVN
|
183 M | $ 62.92 | -0.25 % | $ 3.41 B |  Britain |
 |
Align Technology
ALGN
|
738 M | $ 158.62 | 0.49 % | $ 11.9 B | USA |
 |
NanoVibronix
NAOV
|
-2.52 M | - | - | $ 1.08 M | USA |
 |
Accuray Incorporated
ARAY
|
2.86 M | $ 0.83 | -3.49 % | $ 85.3 M | USA |
|
LENSAR
LNSR
|
-2.28 M | $ 12.03 | 0.17 % | $ 139 M | USA |
 |
IRadimed Corporation
IRMD
|
25.6 M | $ 97.53 | 0.48 % | $ 1.24 B | USA |
 |
Avinger
AVGR
|
-14.4 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
-8.95 M | $ 14.04 | -3.13 % | $ 379 M | USA |
 |
FONAR Corporation
FONR
|
15.3 M | $ 14.51 | -0.13 % | $ 95.1 M | USA |
 |
AxoGen
AXGN
|
4.54 M | $ 32.87 | 0.7 % | $ 1.45 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
3.19 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
-9.68 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
167 M | $ 40.89 | 2.12 % | $ 1.26 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-27 M | $ 17.36 | -0.29 % | $ 401 M | USA |
 |
Globus Medical
GMED
|
521 M | $ 88.38 | -0.15 % | $ 12 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
129 M | $ 12.65 | -0.08 % | $ 974 M | USA |
 |
Aziyo Biologics
AZYO
|
-21.8 M | - | 1.37 % | $ 20.5 M | USA |
 |
Aethlon Medical
AEMD
|
-7.65 M | $ 2.58 | 3.61 % | $ 4.03 M | USA |
 |
Myomo
MYO
|
-10.2 M | $ 1.02 | - | $ 7.19 M | USA |